ICH common technical document working group will begin activities in early 1998.
ICH "COMMON TECHNICAL DOCUMENT" EXPERT WORKING GROUP TO MEET IN EARLY 1998 in the U.S. in conjunction with the next scheduled meeting of the International Conference on Harmonization Steering Committee, Schering-Plough Senior VP-Worldwide Regulatory Affairs Alexander Giaquinto told the ICH 4 conference July 16 in Brussels. ICH has designated the development of a common technical document for new drug submissions in the U.S., the EU and Japan as the primary task for the group over the next two years.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth